Meanwhile, given the crucial impact of TMB and MSI alterations on the efficacy and outcomes of immunotherapies, our research findings have revealed compelling connections between LINC-PINT alterations and TMB as well as MSI in select tumor types. This evidence concerns the gene LINC-PINT and neoplasm.